Skip to main content
NIH funding notice PAR-20-133

Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required)

Closed on June 8, 2021.

Posted
March 11, 2020
Close date
June 8, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $654,559 in first-year total cost, median $221,819.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-T (J3)]3

Most frequent institutions

  1. ENVIVO BIO INC1
  2. PURDUE UNIVERSITY1
  3. TUFTS UNIVERSITY MEDFORD1
Competing awards under PAR-20-133 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Ingestible Pill for spatially targeted sampling of gut microbiome1R21DK132314-01SONKUSALE, SAMEER RTUFTS UNIVERSITY MEDFORD, MA$247,498ZDK1
2022Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring1R21CA260665-01A1SHALON, TIDHAR DARIENVIVO BIO INC, CA$221,819ZDK1
2022Swallowable smart capsule for targeted gastrointestinal microbiome sampling1R21DK128715-01A1CAMPBELL, WAYNE WCROSS, TZU-WEN LIURAHIMI, RAHIMVERMA, MOHIT SINGHPURDUE UNIVERSITY, IN$185,242ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-20-133: Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) | ScienceDex | ConductScience